Core Viewpoint - Origin Agritech Ltd. reported a decline in revenue for the fiscal year 2025, primarily due to equipment upgrades and a reduction in external seed production services, while also highlighting significant partnerships and advancements in research and development [1][4][5]. Business Accomplishments and Highlights for the Year Ended September 30, 2025 - The company established a three-way partnership with China Agricultural University and the Beijing Academy of Agricultural and Forestry Sciences to enhance corn "smart plant type" improvement and innovative variety development [5]. - Origin signed cooperation agreements with 12 agricultural companies at the Sanya International Seed Industry Scientist Conference [5]. - The launch of the "Golden Harvest Club" aimed to strengthen relationships within its distribution ecosystem [5]. - Four new corn varieties were launched, with Jinqiao 8 receiving approval for introduction in five provinces [5]. Financial Results - Revenue for fiscal year 2025 was RMB 91.3 million (US$12.8 million), a decrease from RMB 113.4 million (US$16.2 million) in fiscal year 2024 [4]. - Total operating expenses increased to RMB 64.2 million (US$9.0 million) from RMB 52.7 million (US$7.5 million) in fiscal year 2024 [6]. - The net loss from continuing operations was RMB 58.0 million (US$8.2 million), compared to a net income of RMB 18.7 million (US$2.7 million) in fiscal year 2024 [7]. Liquidity and Cash Flow - As of September 30, 2025, cash and cash equivalents were approximately RMB 15.9 million (US$2.2 million), an increase from RMB 8.4 million (US$1.2 million) in the previous year [8]. - Net cash used in operating activities was RMB 22.9 million (US$3.2 million), compared to RMB 15.0 million (US$2.1 million) in fiscal year 2024 [9]. - Net cash provided by financing activities increased significantly to RMB 44.3 million (US$6.2 million) from RMB 4.5 million (US$0.6 million) in fiscal year 2024 [10]. Management Commentary - The CEO emphasized that fiscal year 2025 was a year of recovery, with a focus on restoring team capabilities and infrastructure, and outlined a three-stage strategic plan for future growth [11].

Core Viewpoint - Origin Agritech Ltd. successfully held its Achievements Exhibition and Seed Industry Innovation Summit, reinforcing its market position and strategic growth initiatives in the agricultural technology sector [1][3]. Group 1: Event Overview - The summit took place on August 9-10, 2025, in Zhengzhou, Henan Province, attracting over 700 distributor partners and more than 30 industry experts [1][2]. - The event served as a platform to showcase Origin's latest product portfolio, including four new corn varieties: Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, which have undergone extensive testing and regulatory approvals [2][4]. Group 2: Distributor Engagement - The summit highlighted strong market interest in the new product offerings, with active participation from distributors in the launch and ordering process [3][4]. - The attendance of over 700 distribution partners underscores the strength of Origin's established channel network and the commercial appeal of its product pipeline [3][4]. Group 3: Strategic Initiatives - CEO Weibin Yan outlined an eight-year strategic development plan aimed at establishing a leading position in China's seed industry during the summit [5]. - The launch of the "Golden Harvest Club," a strategic alliance to strengthen relationships within Origin's distribution ecosystem, was also announced [5]. Group 4: Research and Development - Under the leadership of Vice President and R&D Director Dezhi Deng, Origin's breeding programs focus on developing varieties with enhanced stress tolerance, yield optimization, and commercial viability [4][6]. - Expert presentations from leading agricultural researchers endorsed the new corn varieties, particularly the Jingke 317 variety [6][4]. Group 5: Regulatory Approvals - The new corn varieties have received various regulatory approvals, with Jinqiao 8 approved for introduction in five provinces and Jingke 317 approved in the National Trial [9].